前往化源商城

Blood 2015-03-19

Sp1/Sp3 transcription factors regulate hallmarks of megakaryocyte maturation and platelet formation and function.

Marjolein Meinders, Divine I Kulu, Harmen J G van de Werken, Mark Hoogenboezem, Hans Janssen, Rutger W W Brouwer, Wilfred F J van Ijcken, Erik-Jan Rijkers, Jeroen A A Demmers, Imme Krüger, Timo K van den Berg, Guntram Suske, Laura Gutiérrez, Sjaak Philipsen

文献索引:Blood 125 , 1957-67, (2015)

全文:HTML全文

摘要

Sp1 and Sp3 belong to the specificity proteins (Sp)/Krüppel-like transcription factor family. They are closely related, ubiquitously expressed, and recognize G-rich DNA motifs. They are thought to regulate generic processes such as cell-cycle and growth control, metabolic pathways, and apoptosis. Ablation of Sp1 or Sp3 in mice is lethal, and combined haploinsufficiency results in hematopoietic defects during the fetal stages. Here, we show that in adult mice, conditional pan-hematopoietic (Mx1-Cre) ablation of either Sp1 or Sp3 has minimal impact on hematopoiesis, whereas the simultaneous loss of Sp1 and Sp3 results in severe macrothrombocytopenia. This occurs in a cell-autonomous manner as shown by megakaryocyte-specific (Pf4-Cre) double-knockout mice. We employed flow cytometry, cell culture, and electron microscopy and show that although megakaryocyte numbers are normal in bone marrow and spleen, they display a less compact demarcation membrane system and a striking inability to form proplatelets. Through megakaryocyte transcriptomics and platelet proteomics, we identified several cytoskeleton-related proteins and downstream effector kinases, including Mylk, that were downregulated upon Sp1/Sp3 depletion, providing an explanation for the observed defects in megakaryopoiesis. Supporting this notion, selective Mylk inhibition by ML7 affected proplatelet formation and stabilization and resulted in defective ITAM receptor-mediated platelet aggregation. © 2015 by The American Society of Hematology.

相关化合物

结构式 名称/CAS号 全部文献
5-(((2,5-二氧吡咯烷-1-基)氧基)羰基)-3-羰基-3H-螺-[异苯并呋喃-1,9'-氧杂蒽]-3',6'-二基 二乙酸酯 结构式 5-(((2,5-二氧吡咯烷-1-基)氧基)羰基)-3-羰基-3H-螺-[异苯并呋喃-1,9'-氧杂蒽]-3',6'-二基 二乙酸酯
CAS:150206-05-6
5(6)-羧基二乙酸荧光素琥珀酰亚胺酯(CFDA) 结构式 5(6)-羧基二乙酸荧光素琥珀酰亚胺酯(CFDA)
CAS:150347-59-4
十二烯基丁二酸酐(支链异构体的混和物) 结构式 十二烯基丁二酸酐(支链异构体的混和物)
CAS:26544-38-7